Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety, tolerability, pharmacokinetics and pharmacodynamics of AZD0328 in elderly healthy subjects; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AZD0328

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED